Literature DB >> 3511410

[Controlled study of the analgesic effect and tolerability of buprenorphine in cancer patients].

D Dini, T Fassio, A Gottlieb, M Gini.   

Abstract

The analgesic efficacy and tolerability of a morphine agonist-antagonist buprenorphine are evaluated. The drug is compared to pentazocin. For this purpose, the drugs were randomly administered to 42 patients suffering from pain caused by advanced cancer. Buprenorphine demonstrated a significantly higher analgesic effect than pentazocin and was better tolerated.

Entities:  

Mesh：

Substances：

Year:  1986        PMID： 3511410

Source DB:  PubMed          Journal:  Minerva Med        ISSN： 0026-4806            Impact factor:   4.806


  5 in total

Review 1.  Buprenorphine for treating cancer pain.

Authors:  Mia Schmidt-Hansen; Nathan Bromham; Mark Taubert; Stephanie Arnold; Jennifer S Hilgart
Journal:  Cochrane Database Syst Rev       Date:  2015-03-31

Review 2.  Buprenorphine in cancer pain.

Authors:  Mellar P Davis
Journal:  Support Care Cancer       Date:  2005-07-12       Impact factor: 3.603

Review 3.  Opioid agonist-antagonist drugs in acute and chronic pain states.

Authors:  P J Hoskin; G W Hanks
Journal:  Drugs       Date:  1991-03       Impact factor: 9.546

4.  Buprederm, a new transdermal delivery system of buprenorphine: pharmacokinetic, efficacy and skin irritancy studies.

Authors:  In Park; Dongwon Kim; Jindeog Song; Chang Hoon In; Seung-Wei Jeong; Sang Hun Lee; Bumchan Min; Dongho Lee; Sun-Ok Kim
Journal:  Pharm Res       Date:  2008-02-01       Impact factor: 4.200

Review 5.  A meta-analysis of efficacy and tolerability of buprenorphine for the relief of cancer pain.

Authors:  Cho Naing; Peng Nam Yeoh; Kyan Aung
Journal:  Springerplus       Date:  2014-02-13
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.